ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007 |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
ThermoGenesis Corp.
11431 Sunrise Gold Cir., Suite A
Rancho Cordova, CA, 95742
USA
Press release date: September 19, 2007
RANCHO CORDOVA, Calif., Sept. 19 / -- ThermoGenesis Corp. a leading supplier of innovative products and services that harvest, process, store, and administer therapeutic doses of adult stem cells for trea(TM)ent of disease and injury, announced today that Dr. William Osgood, the Company's Chief Executive Officer, and Mr. Matthew Plavan, Chief Financial Officer, will participate in the 2007 Global Life Sciences Conference to be held September 24 through September 27, 2007 at the Grand Hyatt in New York City. Dr. Osgood is scheduled to present an overview of the Company's business activities, at 1:30PM Eastern time on Thursday, September 27, 2007.
To listen to the audio web cast of the presentation during or after the event, please visit: http://www.thermogenesis.com/investor_relations/index.asp.
The replay of the presentation will also be accessible for 30 days after the conference.
About ThermoGenesis Corp.
ThermoGenesis Corp. (http://www.thermogenesis.com/) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. These products include:
o The BioArchiveŽ System, an automated cryogenic device, is used by cord blood stem cell banks in more than 25 countries for cryopreserving and archiving cord blood stem cell units for transplant. GE Healthcare is the non-exclusive global distribution partner for the BioArchive System.
o AXP(TM) AutoXpress Platform (AXP(TM)) is a proprietary, semi-automated device and companion sterile blood processing disposable for harvesting stem cells from cord blood in a functionally closed system. GE Healthcare is the exclusive global distribution partner for the AXP AutoXpress Platform.
o The CryoSealŽ FS System, an automated device and companion sterile blood processing disposable, is used to prepare fibrin sealants from plasma in about an hour. We received FDA clearance to market the CryoSeal FS System in liver resection surgeries in July 2007. The CryoSeal FS System has received the CE-Mark. From a marketing perspective, the CE Mark is the European equivalent to an FDA approval, in that it allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in Japan and the Company markets through independent distributors in Europe and South America.
o The Thrombin Processing Device(TM)(TPD(TM)) is a sterile blood processing disposable that prepares activated thrombin from a small aliquot of plasma in less than 30 minutes. The CE-Marked TPD is currently being marketed in Europe by Biomet, Inc., subsidiary Biomet Biologics, Medtronic, Inc. and independent distributors.
FCMN Contact: epoutre@thermogenesis.com
Source: ThermoGenesis Corp.
CONTACT: Matthew T. Plavan, +1-916-858-5100, or Ryan Rauch, +1-760-586-8699, both of ThermoGenesis Corp.
Web site: http://www.thermogenesis.com/
|
|
|
|
|
|
|
|
|
|
|
| 
